Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for posttraumatic stress disorder (PTSD). For more information, please visit www.recoverystudy.com or www.clinicaltrials.gov (NCT03841773).

SEC Filings
: All SEC Filings

All SEC Filings

Filter Filings:
Date Form Description Docs XBRL Pages
03/18/19 10-K Annual report pursuant to Section 13 and 15(d) 154
03/11/19 8-K Current report filing
Related Documents
5
03/05/19 8-K Current report filing
Related Documents
175
03/04/19 8-K Current report filing
Related Documents
5
03/01/19 8-K Current report filing
Related Documents
5
02/27/19 4 Saenger Bradley 1
02/27/19 4 Morris Jessica Edgar 1
02/27/19 4 Sullivan Gregory M 1
02/27/19 4 Lederman Seth 1
02/20/19 8-K Current report filing
Related Documents
5